Vivesto AB (0N4A) AI Stock Analysis

Vivesto AB

(LSE:0N4A)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Low leverage and equity cushionA debt-free balance sheet and substantial equity cushion give Vivesto greater financial flexibility than a highly leveraged development-stage biotech. This can support continued research investment and help absorb operating losses, although preserving that cushion depends on improving operations or securing funding.

Negative Factors

Near-zero revenue baseNear-zero reported revenue shows that Vivesto has not yet established a recurring commercial business capable of funding operations. Until a candidate is approved, partnered on meaningful terms, or commercialized, financial performance remains heavily dependent on development progress and available capital.

Vivesto AB (0N4A) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: SEK 85.80M
Dividend Yield: ―
Average Volume (3M): ―
Price to Earnings (P/E): -9.7
Beta (1Y): 0.49
Revenue Growth: ―
EPS Growth: 32.62%
Country: UK
Employees: 4
Sector: Healthcare
Sector Strength: 51
Industry: Drug Manufacturers - Specialty & Generic

Vivesto AB Business Overview & Revenue Model

Company Description

Vivesto AB, established in 1988 and headquartered in Solna, Sweden, specializes in the development, production, commercialization, and sale of pharmaceutical products within human and veterinary oncology, primarily operating in its home country. Its...

Vivesto AB Peers Comparison

Overall Rating

UnderperformOutperform

Sector (51)

Financial Indicators

GB:0N4A against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
SE:NANEXA	52Neutral	SEK 1.97B	-76.50	-22.38%	―	104.76%	37.08%
Sector *	51Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
SE:NICA	46Neutral	SEK 54.25M	0.48	23.67%	―	163.58%	―
SE:SPAGO	43Neutral	SEK 32.09M	-0.85	-106.23%	―	-97.37%	25.28%
SE:SPEC	40Underperform	SEK 20.68M	-0.12	-57.15%	―	―	16.02%
SE:CLS.B	38Underperform	SEK 85.39M	-1.30	-66.41%	―	-47.42%	44.01%

* Healthcare Sector Average

Performance Comparison

GB:0N4A and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0N4A	Vivesto AB	15.80	-4.74	-23.08%
SE:CLS.B	Clinical Laserthermia Systems AB Class B	1.76	-5.87	-76.93%
SE:SPEC	SpectraCure AB	0.01	-0.13	-90.21%
SE:NICA	Nanologica AB	0.17	-1.10	-86.94%
SE:SPAGO	Spago Nanomedical AB	0.04	-0.11	-72.79%
SE:NANEXA	Nanexa AB	10.32	8.51	470.17%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Vivesto AB AI Stock Analysis